Acadia fails in attempt to expand use of antipsychotic to treat patients with depression

Acadia fails in attempt to expand use of antipsychotic to treat patients with depression

Source: 
Stat
snippet: 

Acadia Pharmaceuticals reported negative results Monday from a pair of late-stage clinical trials seeking to expand the use of its antipsychotic medicine Nuplazid to patients with major depressive disorder.